Join
Live feed
·
INSIDERFilingvia Quantisnow
Ginkgo Bioworks Holdings Inc. logo

Director Sloan Harry converted options into 10,822 shares, increasing direct ownership by 4% to 271,418 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DNA· Ginkgo Bioworks Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNA (Ginkgo Bioworks Holdings Inc.) and more on Quantisnow.